How many times a year should I take gemtuzumab/gemtuzumab (MYLOTARG)?

Treatment options for Gemtuzumab/Gemtuzumab (MYLOTARG) will vary based on the patient’s specific situation and the recommendations of the physician. Typically, the use of gemtuzumab/gemtuzumab involves multiple treatment cycles, each cycle including a certain number of intravenous injections. There are usually gaps between treatment cycles to allow the patient to recover and monitor the effects of the treatment.

The specific frequency, dose, and period of treatment will vary based on the patient's age, type and severity of AML, and the patient's general health. Typically, Gemtuzumab/Gemtuzumab may be treated every 2 to 4 weeks, but this is only a general reference, and the specific treatment plan needs to be formulated by a doctor.

Therefore, if you or someone you know is considering gemtuzumab/gemtuzumab for AML treatment, it is strongly recommended to consult with a physician or treatment team for a personalized treatment plan and exact treatment schedule. The doctor will be able to develop the most appropriate treatment plan based on the patient's specific situation to ensure the best results from the treatment.

Gemtuzumab/GemtuzumabIt is not currently on the market in China, so it cannot be included in medical insurance. Patients cannot purchase it domestically and need to purchase it through overseas channelsGemtuzumab/Gemtuzumab. Foreign Gemtuzumab/Gemtuzumab is only Pfizer’s original drug, which is expensive, and the cheaper ones are mainly Turkish original drugs. The price of the drug is around 45,000 yuan, and the price of the original drug in Hong Kong, China is around 65,000 yuan, and the ingredients and efficacy of the original drug are consistent.